Targeting Viral Envelope Glycans Offers Promising Path Toward World's First Broad-Spectrum Antiviral

Targeting viral envelope glycans offers promising path toward world's first broad-spectrum antiviral

Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases.

A broad-spectrum antiviral takes aim at 6 deadly viruses in the lab

Scientists report that targeting sugars on virus surfaces stopped multiple infections, though the approach needs much refinement before human trials.

The newest antiviral, despite its age, has the potential to combat six lethal viruses in mice, but it has a lengthy road to go before it is completed

According to scientists, a sugar on virus envelopes could be transformed into a new antiviral treatment for various viruses, as reported in...